Avadel Pharmaceuticals (AVDL) News Today $11.06 +0.06 (+0.55%) As of 01/3/2025 05:38 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8January 3 at 8:00 AM | globenewswire.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $24.43 Average PT from AnalystsDecember 30, 2024 | americanbankingnews.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has earned a consensus recommendation of "Buy" from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month price target amonDecember 27, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by State Street CorpState Street Corp increased its position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 42.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,623,302 shares of the company's stock after buying an additiDecember 24, 2024 | marketbeat.comBarclays PLC Has $5.15 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Barclays PLC boosted its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 45.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 392,691 shares of the company's stock after acquirDecember 21, 2024 | marketbeat.comAvadel Pharmaceuticals PLC AVDLDecember 20, 2024 | morningstar.comLeerink Partners Remains a Buy on Avadel Pharmaceuticals (AVDL)December 18, 2024 | markets.businessinsider.comInsider Buying: Avadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Purchases 2,300 Shares of StockDecember 17, 2024 | insidertrades.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Position Boosted by Lord Abbett & CO. LLCLord Abbett & CO. LLC grew its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 23.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 489,073 shares of the company's stock after purchasing an additiDecember 17, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Thomas S. Mchugh Purchases 2,300 SharesAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) CFO Thomas S. Mchugh bought 2,300 shares of Avadel Pharmaceuticals stock in a transaction dated Friday, December 13th. The stock was purchased at an average cost of $10.44 per share, for a total transaction of $24,012.00. Following the completion of the acquisition, the chief financial officer now directly owns 87,800 shares of the company's stock, valued at approximately $916,632. The trade was a 2.69 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.December 16, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Up 11.1% in NovemberAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 9,790,000 shares, a growth of 11.1% from the November 15th total of 8,810,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is currently 8.3 days.December 15, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Thomas S. Mchugh Purchases 5,000 SharesDecember 13, 2024 | insidertrades.com48,961 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Acquired by XTX Topco LtdXTX Topco Ltd bought a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 48,961 shares of the company's stock, valued at approximately $642,000. XTX Topco Ltd ownedDecember 13, 2024 | marketbeat.comIndependent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More StockDecember 12, 2024 | finance.yahoo.comAvadel Pharmaceuticals announces publication of findings on sodium oxybateDecember 11, 2024 | markets.businessinsider.comResults from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate TherapyDecember 11, 2024 | finance.yahoo.comLinda Palczuk Acquires 3,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockDecember 11, 2024 | insidertrades.comParkman Healthcare Partners LLC Lowers Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Parkman Healthcare Partners LLC decreased its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 32.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 254,827 shares of the company's stock after sellingDecember 4, 2024 | marketbeat.comAvadel chief commercial officer resigns, stock down 14%December 4, 2024 | msn.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by BrokeragesAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received an average rating of "Buy" from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month priceDecember 2, 2024 | marketbeat.comBraidwell LP Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Braidwell LP grew its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 16.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,388,939 shares of the company's stock after buyingNovember 29, 2024 | marketbeat.comAvadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks RiskyNovember 22, 2024 | seekingalpha.comShort Interest in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Declines By 7.3%Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 9,450,000 shares, a decrease of 7.3% from the October 15th total of 10,190,000 shares. Based on an average daily volume of 934,500 shares, the short-interest ratio is presently 10.1 days.November 18, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for AVDL FY2024 Earnings?Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Research analysts at HC Wainwright lowered their FY2024 earnings per share estimates for Avadel Pharmaceuticals in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst O. Livnat now forecasts that the company will pNovember 15, 2024 | marketbeat.comLeerink Partnrs Has Negative Outlook of AVDL FY2024 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Leerink Partnrs lowered their FY2024 earnings estimates for Avadel Pharmaceuticals in a research note issued on Tuesday, November 12th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earniNovember 15, 2024 | marketbeat.comLifesci Capital Has Strong Forecast for AVDL FY2024 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Research analysts at Lifesci Capital lifted their FY2024 earnings per share estimates for shares of Avadel Pharmaceuticals in a note issued to investors on Tuesday, November 12th. Lifesci Capital analyst M. Belghiti now forecasts that the cNovember 15, 2024 | marketbeat.comStrong Performance and Positive Outlook Drive Buy Rating for Avadel PharmaceuticalsNovember 14, 2024 | markets.businessinsider.comAvadel Pharmaceuticals: Strong Long-Term Potential Despite Market OverreactionNovember 14, 2024 | markets.businessinsider.comAvadel Pharmaceuticals price target lowered to $25 from $27 at H.C. WainwrightNovember 14, 2024 | markets.businessinsider.comAvadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...November 14, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comEquities Analysts Offer Predictions for AVDL FY2027 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research note issued to investors on Wednesday, November 13th. HC Wainwright analyst O. Livnat now forecasts that the company will post earninNovember 14, 2024 | marketbeat.comFY2025 Earnings Estimate for AVDL Issued By Leerink PartnrsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities researchers at Leerink Partnrs decreased their FY2025 earnings per share estimates for shares of Avadel Pharmaceuticals in a report released on Tuesday, November 12th. Leerink Partnrs analyst M. Goodman now expects that the companyNovember 14, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPSAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.03. Avadel Pharmaceuticals had a negative net margin of 111.64% and a negative return on equity of 122.64%. The company had revenue of $50.00 million during the quarter, compared to analyst estimates of $48.43 million. During the same period last year, the business earned ($0.41) earnings per share. Avadel Pharmaceuticals's revenue was up 624.6% compared to the same quarter last year.November 13, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.9% on Analyst DowngradeAvadel Pharmaceuticals (NASDAQ:AVDL) Trading Down 3.9% Following Analyst DowngradeNovember 13, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Lowered to $25.00 at HC WainwrightHC Wainwright reduced their price target on shares of Avadel Pharmaceuticals from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Wednesday.November 13, 2024 | marketbeat.comAvadel Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceNovember 13, 2024 | globenewswire.comAvadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comAvadel Pharmaceuticals' (AVDL) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $22.00 price objective on shares of Avadel Pharmaceuticals in a research note on Tuesday.November 12, 2024 | marketbeat.comAvadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 11, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Recommendation of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been given an average recommendation of "Buy" by the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price objectiveNovember 7, 2024 | marketbeat.comAvadel Pharmaceuticals (AVDL) Scheduled to Post Quarterly Earnings on TuesdayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comAvadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12November 4, 2024 | finance.yahoo.comLoss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-TermNovember 1, 2024 | finance.yahoo.comAvadel Pharmaceuticals (NASDAQ:AVDL) Stock, Insider Trading ActivityNovember 1, 2024 | benzinga.comAvadel announces favorable ruling in admin procedure act litigationOctober 31, 2024 | markets.businessinsider.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $27.00 price target on shares of Avadel Pharmaceuticals in a report on Thursday.October 31, 2024 | marketbeat.comAvadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz LitigationOctober 31, 2024 | marketwatch.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Should You Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Here's WhyOctober 31, 2024 | marketbeat.comIridian Asset Management LLC CT Purchases 50,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Iridian Asset Management LLC CT lifted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 42.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 167,700 shares of the company's stock after purchasing an additionaOctober 31, 2024 | marketbeat.com Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼1.420.87▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼74▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SRRK News Today APLS News Today ALVO News Today RARE News Today OGN News Today VRNA News Today BHVN News Today IMVT News Today PTCT News Today MLTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 1/4/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
